Clotrimazole topical - CPEX Pharmaceuticals

Drug Profile

Clotrimazole topical - CPEX Pharmaceuticals

Alternative Names: Antifungal nail lacquer; Onycofitex

Latest Information Update: 25 Mar 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bentley Pharmaceuticals
  • Developer CPEX Pharmaceuticals
  • Class Antifungals; Imidazoles; Small molecules
  • Mechanism of Action 14-alpha demethylase inhibitors; Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Onychomycosis

Most Recent Events

  • 11 Aug 2008 Discontinued - Phase-II for Onychomycosis in USA (Topical)
  • 23 Jul 2008 Bentley Pharmaceuticals has been acquired by Teva Pharmaceutical Industries
  • 29 Aug 2005 Phase-II clinical trials in Onychomycosis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top